Neonc Technologies (NASDAQ:NTHI) Posts Quarterly Earnings Results

Neonc Technologies (NASDAQ:NTHI) issued its quarterly earnings data on Friday. The company reported ($0.45) earnings per share (EPS) for the quarter, Zacks reports.

Neonc Technologies Trading Up 1.1%

NASDAQ NTHI traded up $0.10 during trading on Friday, reaching $9.08. The company’s stock had a trading volume of 69,119 shares, compared to its average volume of 129,146. The business’s fifty day moving average price is $10.36 and its 200-day moving average price is $7.37. Neonc Technologies has a twelve month low of $3.20 and a twelve month high of $25.00.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reissued a “sell (e)” rating on shares of Neonc Technologies in a research report on Wednesday, October 8th. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the stock currently has a consensus rating of “Sell”.

Hedge Funds Weigh In On Neonc Technologies

Institutional investors have recently added to or reduced their stakes in the stock. Royal Bank of Canada purchased a new stake in Neonc Technologies during the 1st quarter valued at approximately $247,000. Bank of America Corp DE acquired a new position in shares of Neonc Technologies in the second quarter valued at approximately $801,000. Finally, Vanguard Group Inc. purchased a new stake in shares of Neonc Technologies during the third quarter worth approximately $1,279,000.

Neonc Technologies Company Profile

Neonc Technologies Holdings, Inc develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. Its lead products in development include NEO100, which is in Phase 2a clinical trials for treating glioblastoma; and NEO212, a covalently conjugated molecule combining the chemotherapeutic drug temozolomide with perillyl alcohol that is completed preclinical testing.